Safety - onset.to

October 2, 2026

Is HHS too cosy with the psychedelic industry, and is the public being misled about psychedelic risks?

ecstaticintegration.org · Oct 2, 2026 · Jules Evans

September 29, 2026

MAPS opposes the DEA's attempt to place five lesser-known tryptamines into Schedule I under the Controlled Substances Act

maps.org · Sep 29, 2026 · Ismail L. Ali, J.D.

Article Policy Research Safety

September 28, 2026

Kratom-Tee löst bei gesundem 22-Jährigen erstmals in Österreich einen akuten Herzstillstand aus

tirol.orf.at · Sep 28, 2026

Article Clinical HarmReduction Safety DE

September 25, 2026

Scientists identify the LSD structural elements that trigger hallucinations and create a promising non-hallucinogenic antipsychotic analogue

psypost.org · Sep 25, 2026 · Eric W. Dolan

LSD Article Clinical Research Safety

September 24, 2026

Draulio Araújo on the path from ayahuasca research to controlled DMT trials for treatment-resistant depression

behavioralwire.com · Sep 24, 2026 · Editorial Desk

DMT Ayahuasca Article Clinical +2

Psilocybin durably increases sociability in an autism mouse model even when administered under anesthesia

psypost.org · Sep 24, 2026 · Eric W. Dolan

Psilocybin Article Clinical Research Safety

September 23, 2026

First fMRI study of mescaline in awake rats finds reduced cerebellar activity, increased brain connectivity, and frequency-specific sensory filtering

psypost.org · Sep 23, 2026 · Bianca Setionago

Mescaline Article Consciousness Research Safety

A Phase 1 trial tests psilocybin for borderline personality disorder while keeping dialectical behavior therapy in place

behavioralwire.com · Sep 23, 2026 · Editorial Desk

Psilocybin Article Clinical Research Safety

DEA proposes Schedule I classification for five synthetic tryptamine psychedelics, threatening research and clinical development

mindmedicinelaw.com · Sep 23, 2026 · The Psychedelic Journal

Article Policy Research Safety

Warnung vor vermeintlichen THC-Gummibärchen in Berlin mit möglichen synthetischen Opioiden

instagram.com · Sep 23, 2026 · vista_berlin

Cannabis Article Community HarmReduction Safety DE

September 22, 2026

Psilocybin may help the brain recover from repeated concussion, but evidence remains limited to animal research

theconversation.com · Sep 22, 2026 · Argel Aguilar Valles

Psilocybin Article Clinical Research Safety

After an Ayahuasca Retreat: Research-Based Answers to Questions About Integration, Difficulties, Grounding, Community and Help

hummingbirdhealingcenter.org · Sep 22, 2026 · Jim Davis

Psilocybin Ayahuasca Article Integration +2

September 18, 2026

Hilik Magnus describes Magnus Safety's global protocol for rescuing travelers in drug-induced mental health crises

ecstaticintegration.org · Sep 18, 2026 · Jules Evans

Psilocybin Cannabis Article Clinical +2

September 15, 2026

FDA reclassifies NRx's generic ketamine amendment from Major to Minor, setting a November review goal after a vial-cap deficiency

behavioralwire.com · Sep 15, 2026 · Editorial Desk

Ketamine Article Industry Policy Safety

FDA hearing shifts the psychedelic approval debate toward who must deliver treatment and what training, oversight, and safety infrastructure are required

behavioralwire.com · Sep 15, 2026 · Behavioral Wire Staff

Psilocybin Article Clinical Policy Safety

FDA’s Psychedelics Public Hearing Draws Broad Support but No Questions from Federal Panel

psychedelicalpha.com · Sep 15, 2026 · Josh Hardman

Psilocybin Ketamine Article Policy +2

September 14, 2026

Is cannabis a psychedelic? High-dose THC can sometimes produce psychedelic-like experiences, but its chemistry and typical effects differ

leafie.co.uk · Sep 14, 2026 · https://facebook.com/teamleafie/

Psilocybin Cannabis Article Consciousness +2

September 10, 2026

The Case That Shook Céu do Mar: A Santo Daime leader’s acquittal exposes disputes over abuse, authority, and institutional reform

chacruna.net · Sep 10, 2026 · Ali McGhee, Ph.D

LSD Ayahuasca Article Community +2

Preclinical mouse study finds psilocybin may prevent chemotherapy-induced nerve damage by preserving mitochondrial transport

psypost.org · Sep 10, 2026 · Eric W. Dolan

Psilocybin Article Clinical Research Safety

Studie zeigt: Starke Serotonintransporter-Hemmung kann psychedelische Reaktionen bestimmter Tryptamine abschwächen

psychedelia-stiftung.de · Sep 10, 2026 · Markus Berger

Article Clinical Research Safety DE

September 9, 2026

2C-B verändert die funktionelle Organisation des Gehirns ähnlich wie Psilocybin, erzeugt aber ein teilweise eigenes Muster

psychedelia-stiftung.de · Sep 9, 2026 · Markus Berger

Psilocybin 2C-B Article Consciousness +2 DE

September 8, 2026

UC Davis researchers deconstruct LSD to identify molecular features linked to hallucinations, cardiotoxicity and therapeutic drug discovery

ucdavis.edu · Sep 8, 2026 · Katherine E Kerlin

LSD Article Clinical Research Safety

September 7, 2026

Vorläufige Studie: Psilocybin könnte durch Chemotherapie verursachte Nervenschäden verhindern

people.com · Sep 7, 2026 · Rachel Raposas

Psilocybin Article Clinical Research Safety

Psychedelika und Langlebigkeit: Eine neue Forschungsperspektive auf Healthspan und gesundes Altern

psychedelia-stiftung.de · Sep 7, 2026 · Markus Berger

LSD Psilocybin Article Clinical +2 DE

September 5, 2026

Erste Humanstudie zu Psilocin seit den 1960er-Jahren zeigt ähnliche psychedelische Wirkung und bessere Verträglichkeit als Psilocybin

psypost.org · Sep 5, 2026 · Eric W. Dolan

Psilocybin Article Clinical Research Safety DE